SEARCH

SEARCH BY CITATION

References

  • 1
    Nayak N C. Obliterative portal venopathy of the liver, associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol 1969: 87: 359369.
  • 2
    Boyer J L, Sen Gupta K P, Biswas S K et al. Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic hypertension. Ann Intern Med 1967: 66: 4168.
  • 3
    Sama S K, Bhargava S., Gopinath N. et al. Non-cirrhotic portal fibrosis. Am J Med 1971: 51: 160169.
  • 4
    Mukerjee A K, Ramalingaswami V., Nayak N C. Hepatosclerosis – its relationship to intrahepatic portal venous thrombosis. Indian J Med Res 1979: 69: 152160.
  • 5
    Okuda K., Nakashima T., Okudaira M. et al. Anatomic basis of hepatic venographic alteration in idiopathic portal hypertension. Liver 1981: 1: 255263.
  • 6
    Villeneuve J P, Huet P M, Joly J G et al. Idiopathic portal hypertension. Am J Med 1976: 61: 459464.
  • 7
    Altmann H W. Drug-induced liver reactions: a morphological approach. In: GrundmanE., ed. Drug-induced pathology. Current topics in pathology, Vol. 69. Berlin, Heidelberg, New York: Springer Verlag, 1980.
  • 8
    Mikkelsen W P, Edmondson H A, Peters R L, Redeker A G, Reynold T B. Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg 1965: 162: 602620.
  • 9
    Basu Mallik K S, Sen Gupta K P, Bas A K, Biswas S K, Pal N C, Boyer J. Non-cirrhotic portal fibrosis with portal hypertension: A new syndrome. Part II. Histopathologic studies. Indian J Med Res 1967: 55: 351359.
  • 10
    Leevy C M, Popper H., Sherlock S. (Criteria Committee). Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and diagnostic methodology. DHEW (Washington, DC). Publication No. (NIH) 1976, p. 16.
  • 11
    Boyer J L, Hales M R, Klatskin G. “Idiopathic” portal hypertension due to occlusion of intrahepatic portal veins by organised thrombi. A study based on postmortem vinylite-injection corrosion and dissection of the intrahepatic vasculature in 4 cases. Medicine (Baltimore) 1974: 53: 7791.
  • 12
    Wanless I R, Bernier V., Seger M. Intrahepatic portal sclerosis in patients without a history of liver disease. Am J Pathol 1982: 106: 6370.
  • 13
    Aikat B K, Bushnurmat S R, Chhuttiani D V, Mitra S K, Datta D V. The pathology of non-cirrhotic portal fibrosis. Hum Pathol 1979: 10: 405418.
  • 14
    Wanless I R. The role of platelets in the pathogenesis of hepatic fibrosis. Gastroenterology 1979: 76: 1266.
  • 15
    Tomatis L., Magee P N, Shubik P. Induction of liver tumors in Syrian hamsters by feeding dimethylnitrosamine. J Natl Cancer Inst 1964: 33: 341345.
  • 16
    Herrold K McD Histogenesis of malignant liver tumors induced by dimethylnitrosamine. An experimental study in Syrian hamster. J Natl Cancer Inst 1967: 39: 10991104.
  • 17
    Hiraki S. N-N'-dimethylnitrosamine-induced tumors in mice and Syrian hamsters. Acta Med Okayama 1974: 28: 333351.
  • 18
    McLean E K, Hill K R. Portal hypertension in acute experimental veno-occlusive disease of the liver in rats. Br J Exp Pathol 1969: 50: 3741.
  • 19
    Butler W H, Hard G C. Hepatotoxicity of dimethyl-nitrosamine in the rat with special reference to veno-occlusive disease. Exp Mol Pathol 1971: 15: 209219.
  • 20
    Guest J., Ryan C J, Benjamin I S, Blumgart L. Portocaval transposition and subsequent hepatectomy in the rat: Effects on liver atrophy, hypertrophy and regenerative hyperplasia. Br J Exp Pathol 1977: 58: 140146.
  • 21
    Wanless I R, Godwin T A, Allen F., Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine (Baltimore) 1980: 59: 367379.
  • 22
    Paradinas F J, Bull T B, Murray-Lyon I M. Hyperplasia and prolapse of hepatocytes into hepatic veins during long-term methyltestosterone therapy: possible relationships of these changes to the development of peliosis hepatis and liver tumours. Histopathology 1977: 1: 225246.
  • 23
    Shulman H M, McDonald G B, Matthews D. et al. An analysis of hepatic venoocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 1980: 79: 11781191.
  • 24
    Weitz H., Gokel J M, Loeschke K., Possinger K., Eder M. Venoocclusive disease in patients receiving immunosuppressive therapy. Virchows Arch (Pathol Anat) 1982: 395: 245256.
  • 25
    Wolff I A, Wasserman A E. Nitrates, nitrites and nitrosamines. Science 1972: 177: 1519.
  • 26
    Juskiewicz T., Kowalski B., Pastucha E. Occurrence and formation in animal feeds. In: WalkerE A, CriciuteL., CastegnaroM., BörzsönyiM., eds. N-nitroso compounds. Analysis, formation and occurrence. Lyon: IARC Scientific Publications, 1980: 31: 589593.
  • 27
    Weisburger J H, Raineri R. Assessment of human exposure and response to N-nitroso compounds: a new view on the etiology of digestive tract cancers. Toxicol Appl Pharmacol 1975: 31: 369374.
  • 28
    BartschH., CastegnaroM., O'NeillI., OkadaM., eds. N-Nitroso compounds: Occurrence and biological effects. Lyon: IARC Scientific Publications, 1982: 41.
  • 29
    Goodman Z D, Ishak K G. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 1982: 83: 786796.
  • 30
    Walker E A, Castegnaro M., Garren L., Toussaint G., Kowalski B. Intake of volatile nitrosamine from consumption of alcohols. J Natl Cancer Inst 1979: 63: 947951.